American Oriental Bioengineering Inc (AOBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,355 | 9,060 | 9,566 | 13,611 | 33,477 |
| Receivables | 27,228 | 29,240 | 31,949 | 45,544 | 42,342 |
| Inventories | 20,518 | 21,337 | 21,768 | 20,571 | 27,534 |
| Income taxes - deferred | 34 | 34 | 29 | 29 | 3,193 |
| Other current assets | 9,642 | 8,034 | 11,475 | 15,694 | 18,781 |
| TOTAL | $64,777 | $67,704 | $74,787 | $95,449 | $125,327 |
| Non-Current Assets | |||||
| PPE Net | 186,222 | 172,983 | 171,060 | 171,381 | 175,596 |
| Investments And Advances | 303 | 1,505 | 2,350 | 3,338 | 4,162 |
| Intangibles | 158,412 | 158,793 | 157,877 | 158,431 | 169,543 |
| Other Non-Current Assets | 17,911 | 17,820 | 17,654 | 17,710 | 26,534 |
| TOTAL | $362,848 | $351,100 | $348,941 | $350,860 | $375,834 |
| Total Assets | $427,625 | $418,805 | $423,728 | $446,309 | $501,161 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,874 | 4,176 | 65 | 11,055 | 10,694 |
| Accounts payable and accrued liabilities | 26,264 | 7,875 | 29,665 | 27,345 | 24,005 |
| Accrued Expenses | 12,069 | 31,513 | 11,356 | 11,016 | 33,673 |
| TOTAL | $126,314 | $103,819 | $103,428 | $106,212 | $124,458 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,057 | 521 | 537 | 555 | 571 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 17 | -15 |
| TOTAL | $17,635 | $13,092 | $12,585 | $12,511 | $15,201 |
| Total Liabilities | $143,949 | $116,911 | $116,013 | $118,722 | $139,659 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 73 | 73 | 73 | 73 | 73 |
| Common Shares | 550 | 598 | 561 | 524 | 500 |
| Retained earnings | 22,965 | 44,142 | 56,983 | 78,098 | 113,984 |
| Other shareholders' equity | 81,713 | 79,173 | 72,672 | 71,990 | 70,709 |
| TOTAL | $283,676 | $301,893 | $307,715 | $327,587 | $361,503 |
| Total Liabilities And Equity | $427,625 | $418,805 | $423,728 | $446,309 | $501,161 |